LAB
Standard BioTools Inc

5,630
Mkt Cap
$546.08M
Volume
1.00
52W High
$2.25
52W Low
$0.92
PE Ratio
-4.20
LAB Fundamentals
Price
$1.42
Prev Close
$1.38
Open
$1.38
50D MA
$1.29
Beta
1.59
Avg. Volume
1.6M
EPS (Annual)
-$0.5234
P/B
1.36
Rev/Employee
$213,242.05
Loading...
Loading...
News
all
press releases
Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Buys 350,000 Shares
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L bought 350,000 shares of the firm's stock in a transaction dated Wednesday, November 19th. The shares...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Standard BioTools (NASDAQ:LAB) Director Buys $338,250.00 in Stock
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L purchased 275,000 shares of the stock in a transaction that occurred on Tuesday, November 18th. The...
MarketBeat·3d ago
News Placeholder
Casdin Partners Master Fund, L Purchases 450,000 Shares of Standard BioTools (NASDAQ:LAB) Stock
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L purchased 450,000 shares of the business's stock in a transaction on Thursday, November 20th. The stock...
MarketBeat·3d ago
News Placeholder
Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Acquires 350,000 Shares of Stock
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L bought 350,000 shares of the stock in a transaction dated Wednesday, November 19th. The stock was...
MarketBeat·4d ago
News Placeholder
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
Molecular Instruments (MI), the inventor of the HCR imaging platform, and Standard BioTools Inc. (NASDAQ: LAB) today announced a strategic collaboration to develop next-generation Imaging Mass...
Business Wire·6d ago
News Placeholder
Casdin Partners Master Fund, L Buys 225,000 Shares of Standard BioTools (NASDAQ:LAB) Stock
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L acquired 225,000 shares of Standard BioTools stock in a transaction on Monday, November 17th. The shares...
MarketBeat·7d ago
News Placeholder
Casdin Partners Master Fund, L Acquires 250,000 Shares of Standard BioTools (NASDAQ:LAB) Stock
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L purchased 250,000 shares of the business's stock in a transaction dated Friday, November 14th. The shares...
MarketBeat·7d ago
News Placeholder
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Buys 450,000 Shares of Stock
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L acquired 450,000 shares of the firm's stock in a transaction on Thursday, November 13th. The stock was...
MarketBeat·7d ago
News Placeholder
Standard BioTools (NASDAQ:LAB) Director Purchases $274,500.00 in Stock
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L purchased 225,000 shares of the business's stock in a transaction that occurred on Monday, November 17th...
MarketBeat·7d ago
News Placeholder
Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Acquires 300,000 Shares of Stock
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L purchased 300,000 shares of the stock in a transaction that occurred on Tuesday, November 11th. The...
MarketBeat·12d ago

Latest LAB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.